Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC

Published:2019-08-30 Issue:1 Volume:23 Page:160-171
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Zhang Yaqun,Xu Lingfan,Chang Yan,Li YanJing,Butler William,Jin Er,Wang Aifen,Tao Yulei,Chen Xufeng,Liang Chaozhao,Huang Jiaoti

Funder

Foundation for the National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/s41391-019-0172-z.pdf

Reference50 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. https://doi.org/10.3322/caac.21332 .

2. Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet. 2012;44:685–9. https://doi.org/10.1038/ng.2279 .

3. Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, et al. Integrative clinical genomics of advanced prostate. Cancer Cell. 2015;162:454 https://doi.org/10.1016/j.cell.2015.06.053 .

4. Vousden KH, Prives C. Blinded by the light: the growing complexity ofp53. Cell. 2009;137:413–31. https://doi.org/10.1016/j.cell.2009.04.037 .

5. Leroy B, Fournier JL, Ishioka C, Monti P, Inga A, Fronza G, et al. The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis. Nucleic Acids Res. 2013;41(Database issue):D962–9. https://doi.org/10.1093/nar/gks1033 .

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncogenic Phase Transitions: How Mutant p53 Drives Amyloid Formation in p63 and p73 Liquid Droplets;2024-03-30

2. Physiology and pharmacological targeting of phase separation;Journal of Biomedical Science;2024-01-20

3. Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma;Cell Death & Disease;2024-01-11

4. Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?;Current Molecular Pharmacology;2023-11-03

5. Targeting mutant p53 stabilization for cancer therapy;Frontiers in Pharmacology;2023-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3